Executive Capture & Competitive PositionWhat this company is, who pays it, where it can grow or lose
Market RoleEmerging EntrantNot in Top 100 directory
Primary Buying CommandDepartment of the Army
Company Score & Key MetricsRank #2,500 by obligations / #2,500 overall / Small contractor
Expiring Contracts & Active Contracts1 verified records
| PIID | Buying agency | Work | Obligated | End / last action |
|---|---|---|---|---|
| W81XWH15D0037 | Department of the Army | Igf::ot::igf - research&development in support of the us ARMY medical materiel development | -$224K | 2026-01-23 Last action |
Pentagon Budget CrosswalkArmy R-1 / P-1 lines matched to this contractor
| Line | Title | Service | Exhibit | FY request |
|---|---|---|---|---|
| 8260C53101 | MSE Missile | Army | P-1 | $12.2B |
| 8046•••••• | ████████████████ | Army | P-1 | $•••.•M |
| 9214•••••• | ████████████████ | Army | P-1 | $•••.•M |
| 0572•••••• | ████████████████ | Army | P-1 | $•••.•M |
Largest Contracts & OrdersTop 4 of 4 awards (FY2024+)
| Contract ID | Obligated (FY24+) | Type | Agency | Category | Description | Latest Action |
|---|---|---|---|---|---|---|
| W911QY21C0093 | $7.0M | definitive contract | Department of the Army | Defense systems R&D | Stability testing | May 13, 2026 |
| W81XWH15D0037 0002 | -$224K | delivery order | Defense Health Agency | Science and technology R&D | Igf::ot::igf - research&development in support of the us ARMY medical materiel development activity (usammda) for the performance of a phase i, multi-center, randomized, double-blind, placebo-controlled study to assess the long-term ... | Jan 23, 2026 |
| W911QY•••••• | $•••.•M | definitive contract | Department of the Army | ████████████ | ████████████████ | May 12, 2026 |
| DAMD17•••••• | $•••.•M | definitive contract | Defense Contract Management Agency | ████████████ | ████████████████ | Feb 5, 2024 |
Contract Vehicles (IDIQ & BPA)1 parent contract vehicles
| # | Parent Contract ID | Task Orders | Obligated (FY24+) | Vehicle Ceiling | Unused Ceiling | Description | Latest Order |
|---|---|---|---|---|---|---|---|
| 1 | W81XWH15D0037 | 1 | -$224K | $24.2M | - | Igf::ot::igf - research&development in support of the us ARMY medical materiel development activity (usammda) for the performance of a phase i, multi-center, randomized, double-blind, placebo-controlled study to assess the long-term ... | Jan 23, 2026 |
Buying AgenciesFY2024+
| # | Agency | Awards | Obligated | Share |
|---|---|---|---|---|
| 1 | Department of the Army | 2 | $6.7M | -6.9% |
| 2 | Defense Health Agency | 1 | -$224K | 0.2% |
| 3 | Defense Contract Management Agency | 1 | -$102.6M | 107% |
Product & Service CategoriesFY2024+
| # | Category | Awards | Obligated | Share |
|---|---|---|---|---|
| 1 | Defense systems R&D | 1 | $7.0M | -7.3% |
| 2 | Science and technology R&D | 1 | -$224K | 0.2% |
| 3 | Drugs and biologicals | 1 | -$317K | 0.3% |
| 4 | Health R&D | 1 | -$102.6M | 107% |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 24, 2026.
Export Custom Datasets or Query the AwardTape API
Select from 6 core datasets (Contractors, Contract Instruments, Expiring Recompetes, Allied Procurement, HV Grid Queue, Sanctions/UFLPA), filter by company, ticker, or PIID, and export in CSV, JSON, or Markdown Brief.